Stay informed about upcoming cannabis events and conferences with Business of Cannabis. Learn about new products, industry insights, and more.
Last week, the first Cannabis Health Symposium to take place in Germany saw the local industry’s leading telemedicine and pharmacy voices pull apart the rationale behind proposed medical cannabis restrictions.
‘Cannabis Inherits Its Future’ is a three-part feature covering the science, the bottlenecks and the path forward for cannabis breeding, written by Agential Cannabis.
Since April 2024, Berlin has cemented its place as the spiritual centre of the European cannabis industry.
Germany’s medical cannabis market, which has long been the engine powering Europe’s wider market growth, once again finds itself in a state of flux.
Live Cannabis Europa 2026 London, UK From Plant to Patient: Why Genetics Must Lead Medical Cannabis Outcomes Arjan Roskam, Green House Genetics; Dave Auger, Big League Genetics; Adele Hollman, Sanity Group; moderated by Alex Fraser, Grow Group Telemedicine in Germany: Maturity, Regulation and What Comes Next Kristine Lütke, 365 Sherpas GmbH; Dirk Heitepriem, German Cannabis…
As the sun finally dipped over London on the hottest day of the year, the buzz that had filled the Barbican throughout the first day of Cannabis Europa London 2026 moved a few streets east to 83 Rivington, as the tone shifted from debate to celebration.
Live Cannabis Europa 2026 London, UK Cannabis Europa London is back at The Barbican Centre for two days of conversations with global cannabis leaders, policymakers, industry analysts and patient representatives, and, as ever, the sun has shown up.
Tilray Medical, a global leader in medical cannabis research, cultivation, production, products and distribution and a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), today announced its participation in Cannabis Europa London 2026, one of Europe’s leading forums for medical cannabis policy, science, and regulation.
Cannabis Europa London returns on 26-27 May 2026, bringing together operators, investors, clinicians and policymakers from across the global cannabis industry for two days of main stage debate, exhibition, and networking.
